Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
OPERATING ACTIVITIES:
Net income (loss)	$ 887	$ (387)
Adjustments to reconcile to net cash provided (used) by operating activities:
Depreciation and amortization	1,308	1,326
Provision (benefit) for deferred income taxes	99	(74)
Net (gain) loss on disposition of equity-method investments	(269)	0
Impairment of equity-method investments	0	112
Gain on sale of Geismar Interest (Note 3)	(1,095)	0
Impairment of and net (gain) loss on sale of assets and businesses	1,225	867
Amortization of stock-based awards	61	55
Cash provided (used) by changes in current assets and liabilities:
Accounts and notes receivable	118	172
Inventories	(23)	(7)
Other current assets and deferred charges	(11)	(11)
Accounts payable	47	(6)
Accrued liabilities	(161)	129
Other, including changes in noncurrent assets and liabilities	(349)	(79)
Net cash provided (used) by operating activities	1,837	2,097
FINANCING ACTIVITIES:
Proceeds from (payments of) commercial paper – net	(93)	(499)
Proceeds from long-term debt	3,013	5,708
Payments of long-term debt	(5,475)	(4,966)
Proceeds from issuance of common stock	2,130	8
Dividends paid	(744)	(1,111)
Dividends and distributions paid to noncontrolling interests	(636)	(715)
Contributions from noncontrolling interests	15	27
Payments for debt issuance costs	(14)	(8)
Contribution to Gulfstream for repayment of debt	0	(148)
Other – net	(87)	(16)
Net cash provided (used) by financing activities	(1,891)	(1,720)
INVESTING ACTIVITIES:
Capital expenditures (1)	(1,700)	(1,577)
Dispositions – net	(27)	29
Proceeds from sale of businesses, net of cash divested	2,056	712
Proceeds from dispositions of equity-method investments	200	0
Purchases of and contributions to equity-method investments	(103)	(132)
Distributions from unconsolidated affiliates in excess of cumulative earnings	394	341
Other – net	236	227
Net cash provided (used) by investing activities	1,056	(400)
Increase (decrease) in cash and cash equivalents	1,002	(23)
Cash and cash equivalents at beginning of year	170	100
Cash and cash equivalents at end of period	1,172	77
(1) Increases to property, plant, and equipment	(1,826)	(1,468)
Changes in related accounts payable and accrued liabilities	126	(109)
Capital expenditures (1)	$ (1,700)	$ (1,577)